SML Mahindra: DRP dismisses appeal against transfer pricing order
SML Mahindra's appeal against a draft assessment order related to Transfer Pricing dismissed by DRP. The company will file an appeal against the final assessment order.
The monetary amount is not very material and the company has the option to appeal. Therefore, the impact is low.
The announcement discusses the dismissal of the company's appeal by the Dispute Resolution Panel, which has a negative implication for the company.
* The Dispute Resolution Panel (DRP) of Income Tax dismissed SML Mahindra's appeal against a draft assessment order related to Transfer Pricing Order u/s 92CA(3) dated 25 January 2025 (AY2022-23). * The draft assessment order, issued under section 144C (1) by the AO on 7 March 2025, included adjustments of ₹9.92 Lakhs. * DRP directed the AO to pass the final assessment order. * The company will file an appeal against the final Assessment Order to be issued by the AO. * The authority has disputed the Arm’s Length Price and Method adopted by the Company for payment of Corporate Guarantee fee to the AE. * The order was received on 21 November 2025.
What to do with a filing like this
SML Mahindra Limited filed this with the NSE as a statutory disclosure, categorised under litigation updates. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by SML Mahindra Limited. Read the original for the full detail.